Novo Nordisk A/S (BVMF:N1VO34)

Novo Nordisk Revenue

Novo Nordisk had revenue of 74.98B DKK in the quarter ending September 30, 2025, with 5.14% growth. This brings the company's revenue in the last twelve months to 315.60B, up 16.64% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

• Revenue (ttm): 315.60B DKK
• Revenue Growth: +16.64%
• P/S Ratio: 4.87
• Revenue / Employee: 4.08M DKK
• Employees: 77,349
• Market Cap: 1.29T BRL

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	290.40B	58.14B	25.03%
Dec 31, 2023	232.26B	55.31B	31.26%
Dec 31, 2022	176.95B	36.15B	25.68%
Dec 31, 2021	140.80B	13.85B	10.91%
Dec 31, 2020	126.95B	4.93B	4.04%
Dec 31, 2019	122.02B	10.19B	9.11%
Dec 31, 2018	111.83B	135.00M	0.12%
Dec 31, 2017	111.70B	-84.00M	-0.08%
Dec 31, 2016	111.78B	3.85B	3.57%
Dec 31, 2015	107.93B	19.12B	21.53%
Dec 31, 2014	88.81B	5.23B	6.26%
Dec 31, 2013	83.57B	5.55B	7.11%
Dec 31, 2012	78.03B	11.68B	17.60%
Dec 31, 2011	66.35B	5.57B	9.16%
Dec 31, 2010	60.78B	9.70B	18.99%
Dec 31, 2009	51.08B	5.53B	12.13%
Dec 31, 2008	45.55B	3.72B	8.90%
Dec 31, 2007	41.83B	3.09B	7.97%
Dec 31, 2006	38.74B	4.98B	14.76%
Dec 31, 2005	33.76B	-	-